Prevalence Rates of Arterial Hypertension According to the Threshold Criteria of 140/90 or 130/80 mmHg and Associated Cardiometabolic and Renal Factors: SIMETAP-HTN Study
Visualitza/
Impacte
Scholar |
Altres documents de l'autoria: Pallarés-Carratalá, Vicente; Ruiz-Garcia, Antonio; Serrano-Cumplido, Adalberto; Arranz-Martínez, Ezequiel; DIVISÓN GARROTE, JUAN ANTONIO; Moyá Amengual, Ana; Escobar, Carlos; barrios, vivencio
Metadades
Mostra el registre complet de l'elementcomunitat-uji-handle:10234/9
comunitat-uji-handle2:10234/36080
comunitat-uji-handle3:10234/36082
comunitat-uji-handle4:
INVESTIGACIONMetadades
Títol
Prevalence Rates of Arterial Hypertension According to the Threshold Criteria of 140/90 or 130/80 mmHg and Associated Cardiometabolic and Renal Factors: SIMETAP-HTN StudyAutoria
Data de publicació
2023Editor
MDPIISSN
1010-660X; 1648-9144Cita bibliogràfica
Pallarés-Carratalá, V.; Ruiz-García, A.; Serrano-Cumplido, A.; Arranz-Martínez, E.; Divisón-Garrote, J.A.; Moyá-Amengual, A.; Escobar-Cervantes, C.; Barrios, V. Prevalence Rates of Arterial Hypertension According to the Threshold Criteria of 140/90 or 130/80 mmHg and Associated Cardiometabolic and Renal Factors: SIMETAP-HTN Study. Medicina 2023, 59, 1846. https://doi.org/ 10.3390/medicina59101846Tipus de document
info:eu-repo/semantics/articleVersió
info:eu-repo/semantics/publishedVersionParaules clau / Matèries
Resum
Background and objectives: Arterial hypertension (HTN) is the leading preventable cause
of atherosclerotic cardiovascular diseases (ASCVD) and death from all causes. This study aimed
to determine the prevalence rates ... [+]
Background and objectives: Arterial hypertension (HTN) is the leading preventable cause
of atherosclerotic cardiovascular diseases (ASCVD) and death from all causes. This study aimed
to determine the prevalence rates of HTN diagnosed according to the threshold diagnostic criteria
130/80 mmHg and 140/90 mmHg, to compare blood pressure (BP) control, and to evaluate their
associations with cardiovascular diseases and cardiometabolic and renal risk factors. Materials and
Methods: This was a cross-sectional observational study conducted in primary care with a population-
based random sample: 6588 people aged 18.0–102.8 years. Crude and adjusted prevalence rates of
HTN were calculated. BP control was compared in HTN patients with and without ASCVD or chronic
kidney disease (CKD). Their associations with cardiovascular diseases and cardiometabolic and renal
factors were assessed using bivariate and multivariate analysis. Results: Adjusted prevalence rates
of HTN diagnosed according to 140/90 and 130/90 criteria were 30.9% (32.9% male; 29.7% female)
and 54.9% (63.2% male; 49.3% female), respectively. BP < 130/80 mmHg was achieved in 60.5%
of HTN patients without ASCVD or CKD according to 140/90 criterion, and 65.5% according to
130/80 criterion. This BP-control was achieved in 70% of HTN patients with ASCVD and 71% with
CKD, according to both criteria. Coronary heart disease (CHD), heart failure, atrial fibrillation, stroke,
diabetes, prediabetes, low glomerular filtration rate (eGFR), hyperuricemia, hypercholesterolemia,
obesity, overweight, and increased waist-to-height ratio were independently associated with HTN
according to both criteria. Conclusions: Almost a third of the adult population has HTN according to
the 140/90 criterion, and more than half according to the 130/90 criterion, with a higher prevalence
in men. The main clinical conditions associated with HTN were heart failure, diabetes, CHD, low
eGFR, and obesity. [-]
Publicat a
Medicina 2023, 59, 1846Entitat finançadora
SIMETAP
Codi del projecte o subvenció
05/2010RS
Drets d'accés
info:eu-repo/semantics/openAccess
Apareix a les col.leccions
- MED_Articles [667]